Broad-spectrum cardioprotection with adenosine

Annals of Thoracic Surgery

Volumn 68, Issue 5, 1999, Pages 1942-1948

  Vinten Johansen, Jakob ^a   Thourani, Vinod H ^a   Ronson, Russell S ^a   Jordan, James E ^a   Zhao, Zhi Qing ^a   Nakamura, Masanori ^a   Velez, Daniel ^a   Guyton, Robert A ^a  

^a Division of Cardiothoracic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; POTASSIUM CHANNEL;

ANTIINFLAMMATORY ACTIVITY; CHANNEL GATING; CONFERENCE PAPER; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

ADENOSINE; ANIMALS; CARDIOPLEGIC SOLUTIONS; HEART ARREST, INDUCED; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY;

EID: 0032754089     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01018-8     Document Type: Conference Paper

References (42)

1. Berne R.M. The role of adenosine in the regulation of coronary blood flow. Circ Res. 47:1980;807-813.
2. Lasley R.D., Mentzer R.M. Jr. Protective effects of adenosine in the reversibly injured heart. Ann Thorac Surg. 60:1995;843-846.
3. Zhao Z.-Q., McGee D.S., Nakanishi K., et al. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation. 88:1993;709-719.
4. Olafsson B., Forman M.B., Puett D.W., et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine importance of the endothelium and the no-reflow phenomenon . Circulation. 76:1987;1135-1145.
5. Cronstein B.N., Kramer S.B., Weissmann G., Hirschhorn R. Adenosine a physiological modulator of superoxide anion generation by human neutrophils . J Exp Med. 158:1983;1160-1177.
6. Kitakaze M., Hori M., Sato H., et al. Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res. 69:1991;1402-1408.
7. Colli S., Tremoli E. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes adenosine-dependent and adenosine-independent mechanisms . J Lab Clin Med. 118:1991;136-145.
8. Lefer A.M., Tsao P.S., Lefer D.J., Ma X.-L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J. 5:1991;2029-2034.
9. 2 receptors. J Immunol. 148:1992;2201-2206.
10. Sluiter W., Pietersma A., Lamers J.M.J., Koster J.F. Leukocyte adhesion molecules on the vascular endothelium their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression . J Cardiovasc Pharmacol. 22:(Suppl 4):1993;37-44.
11. Cronstein B.N., Levin R.I., Belanoff J., Weissmann G., Hirschhorn R. Adenosine an endogenous inhibitor of neutrophil-mediated injury to endothelial cells . J Clin Invest. 78:1986;760-770.
12. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol. 271:1996;H1456-H1464.
13. Nolte D., Lorenzen A., Lehr H.A., Zimmer F.J., Klotz K.N., Messmer K. Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn-Schmiedebergs Archives of Pharmacology. 346:1992;234-237.
14. Williams M.W., Jordan J.E., Fernandez A.Z., Zhao Z.-Q., Vinten-Johansen J. Adenosine (ADO) inhibits unactivated neutrophil (PMN) adherence to thrombin stimulated coronary vascular endothelium (EC) by a p-selectin mechanism. [abstract] FASEB J. 10:1996;280.
15. 2-receptor mechanism. [Abstract] FASEB J. 10:1996;611.
16. 3 adenosine receptor activation reduces PMN-endothelial cell interaction without effect on free radicals and degranulation. Circulation. 98:1998;666.
17. Randhawa M.P.S. Jr, Lasley R.D., Mentzer R.M. Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning. J Thorac Cardiovasc Surg. 110:1995;63-74.
18. 1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol. 22:1990;39-47.
19. 1 receptor mechanism. Am J Physiol. 263:1992;H1460-H1465.
20. Pitarys C.J., Virmani R., Vildibill H.D. Jr, Jackson E.K., Forman M.B. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation. 83:1991;237-247.
21. Zhao Z-Q, Nakamura M, Wang N-P, Wilcox JN, Shearer ST, Katzmark S, Vinten-Johansen J. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocyte cells. Coronary Artery Dis 1999; in press.
22. Todd J.C., Zhao Z.-Q., Williams M.W., Sato H., Van Wylen D.G.L., Vinten-Johansen J. Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence. Ann Thorac Surg. 62:1996;1364-1372.
23. Woolfson R.G., Patel V.C., Yellon D.M. Pre-conditioning with adenosine leads to concentration-dependent infarct size reduction in the isolated rabbit heart. Cardiovasc Res. 31:1996;148-151.
24. Toombs C.F., McGee D.S., Johnston W.E., Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation. 86:1992;986-994.
25. Jennings R.B. Myocardial ischemia-observation, definitions, and speculations. J Mol Cell Cardiol. 1:1970;345-349.
26. Zhou Z., Bunger R., Lasley R.D., Hegge J.O., Mentzer R.M. Jr. Adenosine pretreatment increases cytosolic phosphorylation potential and attenuates postischemic cardiac dysfunction in swine. Surg Forum. 1993;249-251.
27. 1-selective adenosine analogues protects the heart against infarction. Circulation. 85:1992;659-665.
28. Randhawa M.P.S. Jr, Lasley R.D., Mentzer R.M. Jr. Adenosine and the stunned heart. J Card Surg. 8:(Suppl):1993;332-337.
29. Lee H.T., LaFaro R.J., Reed G.E. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg. 10:1995;665-676.
30. Hearse D.J., Stewart D.A., Braimbridge M.V. Cellular protection during myocardial ischemia. The development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation. 54:1976;193-202.
31. Schubert T., Vetter H., Owen P., Reichart B., Opie L.H. Adenosine cardioplegia adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart . J Thorac Cardiovasc Surg. 98:1989;1057-1065.
32. Thelin S., Hultman J., Ronquist G. Effects of adenosine infusion on the pig heart during normothermic ischemia and reperfusion. Scand J Thorac Cardiovasc Surg. 25:1991;207-213.
33. De Jong J.W., van der Meer P., van Loon H., Owen P., Opie L.H. Adenosine as adjunct to potassium cardioplegia effect on function, energy metabolism, and electrophysiology . J Thorac Cardiovasc Surg. 100:1990;445-454.
34. Hohlfeld T., Hearse D.J., Yellon D.M., Isselhard W. Adenosine-induced increase in myocardial ATP are there beneficial effects for the ischaemic myocardial? Bas Res Cardiol. 84:1989;499-509.
35. Hudspeth D.A., Nakanishi K., Vinten-Johansen J., et al. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann Thorac Surg. 58:1994;1637-1644.
36. Stambaugh K., Jacobson K.A., Jiang J.-L., Liang B.T. A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia. Am J Physiol. 273:1997;H501-H505.
37. 3 receptor involvement . Cardiovasc Res. 28:1994;1049-1056.
38. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res. 28:1994;1057-1061.
39. 3 receptor stimulation attenuates global ischemic-reperfusion injury in a neutrophil-free model. Circulation. 96:1997;743.
40. 3 receptor agonist before cardioplegia arrest improves postischemic function of jeopardized myocardium. Surg Forum. 49:1998;207-209.
41. Bolling S.F., Bies L.E., Gallagher K.P., Bove E.L. Enhanced myocardial protection with adenosine. Ann Thorac Surg. 47:1989;809-815.
42. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.